Obesity Science & Practice
doi: 10.1002/osp4.46
ORIGINAL ARTICLE
Characteristics of patients potentially eligible for pharmacotherapy for weight loss in primary care practice in the United States Shumin Zhang1, Sudhakar Manne2, Jennifer Lin2 and Jiao Yang2 1
Epidemiology, Takeda Development Center Americas, Inc., Deerfield, IL USA; 2 Safety Statistics, Takeda Development Center Americas, Inc., Deerfield, IL USA Received 7 January 2016; revised 20 April 2016; accepted 21 April 2016 Address for correspondence: Shumin Zhang, MD, ScD, Takeda Development Center Americas, Inc., Deerfield, IL 60015, USA. E-mail:
[email protected]
Summary Objective To describe the characteristics of real-world patients potentially eligible for adjunctive pharmacotherapy for weight loss.
Methods Patients from the GE Centricity electronic medical record database were selected if they 2 had body mass index (BMI) ≥30 or ≥27 to